Barrett's esophagus. Practical issues for daily routine diagnosis

Area of Science:

• Gastroenterology and Pathology
• Oncology
• Histopathology

Background:

• Barrett's esophagus (BE) is recognized as a precancerous condition, yet its definition remains debated globally, particularly regarding the necessity of goblet cells.
• The presence or absence of goblet cells in BE definitions complicates diagnosis and management.
• Emerging evidence suggests Barrett's adenocarcinoma may arise from areas without goblet cells, challenging traditional understandings.

Purpose of the Study:

• To clarify the diagnostic criteria for Barrett's esophagus and its associated neoplasia.
• To highlight the critical information pathologists must provide to gastroenterologists for effective patient management.
• To emphasize the importance of accurate histological grading and risk factor assessment in Barrett's esophagus.

Main Methods:

• Review of current definitions and diagnostic challenges in Barrett's esophagus.
• Analysis of the role of goblet cells in BE pathogenesis and adenocarcinoma development.
• Discussion of the information required for therapeutic decision-making in BE management.

Main Results:

• Histological diagnosis of neoplasia in BE is frequently hindered by significant interobserver variability.
• New endoscopic techniques facilitate local resection of neoplasia with curative intent.
• Key information for gastroenterologists includes the presence/absence of neoplasia, its grade (low/high grade, carcinoma), and risk factors.

Conclusions:

• Accurate histological assessment of Barrett's esophagus is vital for distinguishing between surveillance and therapeutic strategies.
• Pathologists must provide specific details on neoplasia grade and risk factors (e.g., vessel permeation, differentiation, resection completeness, infiltration depth) to guide gastroenterologists.
• Standardizing definitions and improving interobserver agreement in BE histology are essential for optimal patient care and cancer prevention.